Key Drivers
- High Capital Returns
- Weak Cash Conversion
- Intangible-heavy Assets
AIAI Summary
UFPT still has a strong profitability engine and balance sheet, but the thesis has shifted from “high-growth compounder” to “execution-sensitive premium stock” as Q1 revenue slowed to 4.1% and launch/labor costs weakened cash conversion, making reacceleration in growth and cash flow the key test for whether the current valuation is justified.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High Capital Returns
- •Weak Cash Conversion
- •Intangible-heavy Assets
UFPT combines strong margins, high capital returns, and solid liquidity, but weaker quarterly cash conversion, heavy intangibles, and a premium valuation temper the investment case.
Price Behavior
Key Price Behavior Insights:
- •Uptrend intact
- •Momentum cooled
- •Support test ahead
UFPT remains in an uptrend over the last month, but the post-5/8 pullback has cooled momentum and leaves $212-$214 support as the key near-term test.
Sharp pullback after the 2026-05-08 breakout erased part of the advance and signaled profit-taking
Sentiment & News
Key News Insights:
- •EPS beat
- •Modest growth
- •Stable quarter
UFPT delivered a steady Q1, with 4.1% sales growth, modest profit improvement, and EPS of $2.48 beating expectations.
The results are mildly positive for UFPT, reinforcing operational stability while showing only modest year-over-year earnings momentum
Similar Companies in Healthcare
Other companies in the same sector with AI ratings